Vor Biopharma Inc (VOR) Stock Analysis

Vor Biopharma Inc (VOR) is a publicly traded company in the HEALTHCARE sector. It trades at $13.66, carries a market capitalization of $811.16M. This page summarizes the public market data, fundamentals, and frequently asked questions for VOR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.66
• Market Cap: $811.16M
• EPS: $-70.40
• 52-Week High: $65.80
• 52-Week Low: $3.62

Market Sentiment

Vor Biopharma Inc currently has a Neutral sentiment score of 0.01.

About Vor Biopharma Inc

Vor Biopharma Inc. is a cutting-edge biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative hematopoietic stem cell (eHSC) therapies for cancer treatment. Utilizing proprietary technology platforms, the company strives to create targeted therapies that significantly improve patient outcomes, including durable responses and overall survival. Vor's focus on advancing cell therapies places it at the vanguard of the dynamic oncology market, present...

GNG Research Analysis

GNG Research scores Vor Biopharma Inc (VOR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VOR.

Frequently Asked Questions

Does VOR pay dividends?

Vor Biopharma Inc (VOR) does not currently pay a regular dividend.

What is VOR's market cap?

Vor Biopharma Inc (VOR) has a market capitalization of $811.16M with a current stock price of $13.66.